Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs
Susannah Bloch, JEE-YAU LEE, Thomas Syburra, et al.
Thorax (2014) Vol. 70, Iss. 3, pp. 219-228
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Clinical review: intensive care unit acquired weakness
Greet Hermans, Greet Van den Berghe
Critical Care (2015) Vol. 19, Iss. 1
Open Access | Times Cited: 617
The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases
Vicky Wang-Wei Tsai, Yasmin Husaini, Amanda Sainsbury, et al.
Cell Metabolism (2018) Vol. 28, Iss. 3, pp. 353-368
Open Access | Times Cited: 335
Sarcopenia: assessment of disease burden and strategies to improve outcomes
Ilaria Liguori, G. Russo, Luisa Aran, et al.
Clinical Interventions in Aging (2018) Vol. Volume 13, pp. 913-927
Open Access | Times Cited: 261
Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19
M Soares, Moritz Eggelbusch, Elie Naddaf, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 1, pp. 11-22
Open Access | Times Cited: 197
Biomarkers in sarcopenia: A multifactorial approach
Francesco Curcio, Gaetana Ferro, Claudia Basile, et al.
Experimental Gerontology (2016) Vol. 85, pp. 1-8
Closed Access | Times Cited: 188
The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Samuel N. Breit, David A. Brown, Vicky Wang-Wei Tsai
Annual Review of Physiology (2020) Vol. 83, Iss. 1, pp. 127-151
Closed Access | Times Cited: 140
GDF15, an emerging key player in human aging
Maria Conte, Cristina Giuliani, Antonio Chiariello, et al.
Ageing Research Reviews (2022) Vol. 75, pp. 101569-101569
Open Access | Times Cited: 89
Sarcopenia – The search for emerging biomarkers
Alexander Kalinkovich, Gregory Livshits
Ageing Research Reviews (2015) Vol. 22, pp. 58-71
Closed Access | Times Cited: 169
Exercise increases circulating GDF15 in humans
Maximilian Kleinert, Christoffer Clemmensen, Kim A. Sjøberg, et al.
Molecular Metabolism (2018) Vol. 9, pp. 187-191
Open Access | Times Cited: 137
mTORC1 underlies age‐related muscle fiber damage and loss by inducing oxidative stress and catabolism
Huibin Tang, Ken Inoki, Susan V. Brooks, et al.
Aging Cell (2019) Vol. 18, Iss. 3
Open Access | Times Cited: 128
Regulation of myokine expression: Role of exercise and cellular stress
Mario Ost, Verena Coleman, Juliane Kasch, et al.
Free Radical Biology and Medicine (2016) Vol. 98, pp. 78-89
Closed Access | Times Cited: 120
Growth differentiation factor‐15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo
Mehul S. Patel, Jen Lee, Manuel Baz, et al.
Journal of Cachexia Sarcopenia and Muscle (2015) Vol. 7, Iss. 4, pp. 436-448
Open Access | Times Cited: 103
Intensive Care Unit-Acquired Weakness: Not Just Another Muscle Atrophying Condition
Heta Lad, Tyler M. Saumur, Margaret S. Herridge, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7840-7840
Open Access | Times Cited: 96
Effects of elastic band resistance training and nutritional supplementation on muscle quality and circulating muscle growth and degradation factors of institutionalized elderly women: the Vienna Active Ageing Study (VAAS)
Marlene Hofmann, Barbara Schober-Halper, Stefan Oesen, et al.
European Journal of Applied Physiology (2016) Vol. 116, Iss. 5, pp. 885-897
Open Access | Times Cited: 92
Physiotherapy management of intensive care unit-acquired weakness
Carol Hodgson, Claire J. Tipping
Journal of physiotherapy (2016) Vol. 63, Iss. 1, pp. 4-10
Open Access | Times Cited: 90
Growth differentiation factor 15 predicts advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease
Bo Kyung Koo, Sung Hee Um, Dong Soo Seo, et al.
Liver International (2017) Vol. 38, Iss. 4, pp. 695-705
Closed Access | Times Cited: 89
Growth differentiation factor 15: A novel biomarker with high clinical potential
Stéphanie Desmedt, Valérie Desmedt, Leen De Vos, et al.
Critical Reviews in Clinical Laboratory Sciences (2019) Vol. 56, Iss. 5, pp. 333-350
Closed Access | Times Cited: 84
The Role of GDF15 as a Myomitokine
Kornelia Johann, Maximilian Kleinert, Susanne Klaus
Cells (2021) Vol. 10, Iss. 11, pp. 2990-2990
Open Access | Times Cited: 81
A new paradigm in sarcopenia: Cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction
Danbi Jo, Gwangho Yoon, Oh Yoen Kim, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112636-112636
Open Access | Times Cited: 49
GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway
Wanli Zhang, Weikuan Sun, Xiaofan Gu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 41
Factors mediating exercise‐induced organ crosstalk
Rugivan Sabaratnam, Jørgen F. P. Wojtaszewski, Kurt Højlund
Acta Physiologica (2022) Vol. 234, Iss. 2
Open Access | Times Cited: 40
GDF15 as a key disease target and biomarker: linking chronic lung diseases and ageing
Yang Wan, Jianhua Fu
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 3, pp. 453-466
Open Access | Times Cited: 22
miR‐424‐5p reduces ribosomal RNA and protein synthesis in muscle wasting
Martin Connolly, Richard Paúl, Roser Farre Garros, et al.
Journal of Cachexia Sarcopenia and Muscle (2017) Vol. 9, Iss. 2, pp. 400-416
Open Access | Times Cited: 74
MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit–acquired Weakness
Roser Farre Garros, Richard Paúl, Martin Connolly, et al.
American Journal of Respiratory and Critical Care Medicine (2017) Vol. 196, Iss. 11, pp. 1422-1433
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top